Xilio Therapeutics, Inc.XLONASDAQ
Loading
Research and development spending
3Y CAGR
-7.6%/yr
Annual compound
5Y CAGR
+1.3%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $46.75M | +13.4% |
| 2024 | $41.21M | -21.0% |
| 2023 | $52.14M | -11.9% |
| 2022 | $59.20M | +15.7% |
| 2021 | $51.19M | +16.6% |
| 2020 | $43.91M | +208.0% |
| 2019 | $14.26M | - |